Suits Claims Drug Maker Paid for Off-Label Uses

Six lawsuits filed in federal courts claim Schering-Plough Corp. offered bribes and kickbacks to physicians to prescribe medications for off-label uses.

The suits, pending in New Jersey and Arizona, claim the Kenilworth, N.J.-based company paid physicians to prescribe its cancer and hepatitis drugs, according to the New Jersey Law Journal. Plaintiffs include health insurers, unions and consumers.

Schering-Plough, based in Kenilworth, N.J., paid a $180 million fine as part of a plea deal last year to settle a federal investigation into its marketing practices, the newspaper says. Prosecutors had alleged the company sometimes spent hundreds of dollars a patient in entertainment or payments for sitting on advisory boards or other activities.

Schering-Plough filed a motion on Thursday seeking to move the Arizona litigation to New Jersey.

We welcome your comments, but please adhere to our comment policy and the ABA Code of Conduct.

Commenting is not available in this channel entry.